ClinicalTrials.govpublic full text
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
cerebrovascular accident, chronic obstructive pulmonary disease, chronic renal failure, coronary artery disease, diabetes mellitus, malignant neoplasm
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 181711
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.